Home/Stocks/Financials

JPMorgan European Growth & Income PLC

JEGI.L·Financials·Market Cap £808m
Rank #213 of 280
Quantitative Model · 280 Stocks Analysed
£1.35
-3.57% YTD
52W: £1.25 - £1.53

Factor Analysis Summary

Editorial assessment generated from JPMorgan European Growth & Income PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, JPMorgan European Growth & Income PLC (JEGI.L) currently holds an overall rank of #213 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include valuation (P/E 5.8), where it demonstrates compelling valuation metrics, trading at a discount to peer averages on key multiples; solvency (debt/equity 0.1), where it demonstrates a robust solvency position with conservative leverage and strong balance sheet coverage; and profitability (ROE 18.3%, net margin 93.5%), where it demonstrates strong profitability metrics, ranking in the top quartile for earnings quality and return on capital.

Areas requiring attention include asset efficiency, where poor capital efficiency suggests assets may be underutilised or overvalued on the balance sheet, as well as technical (RSI 16.7), where price momentum is flat with technical indicators offering no clear signal.

Within the Financials sector, JPMorgan European Growth & Income PLC sits at composite rank #213, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

Despite its mid-table composite rank of #213, JPMorgan European Growth & Income PLC shows selective strength — notably in valuation and solvency — suggesting a stock with identifiable merits alongside clear areas for improvement.

Strongest Factors

  • Valuation — Rank 25/280 (top quartile)
  • Solvency — Rank 45/280 (top quartile)
  • Profitability — Rank 54/280 (top quartile)

Weakest Factors

  • Asset Efficiency — Rank 179/280 (below average)
  • Technical — Rank 140/280 (middle of the pack)

Score Analysis

JPMorgan European Growth & Income PLC is ranked #213 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

88/280
Average Score
Liquidity
Good103/280
Valuation
Excellent25/280
Profitability
Excellent54/280
Solvency
Excellent45/280
Asset Efficiency
Weak179/280
Mkt Trading
Excellent67/280
Technical
Fair140/280

1. Liquidity

Score: 103/280

How liquid is JEGI and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current Ratio23.46x
Range: N/ARank 6/280
–
TTM Operating Cash Flow25.31x
Range: N/ARank 5/280
–
Liquidity Coverage RatioN/A
Range: 100-150
–
Intangible Asset RatioN/A
Range: 10 - 30Rank 193/280
–
Cash-to-Debt Ratio0.26x
Range: N/ARank 133/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
23.46x
Sector: N/A

Overall Liquidity Rank

Rank within universe#103/280
Best (1)Worst (280)

2. Valuation

Score: 25/280

Is JEGI undervalued compared to its peers and fair value metrics?

2/7
valuation criteria met
–
FY27e P/EN/A
Range: 8x - 18x
–
FY26e P/EN/A
Range: 8x - 18x
–
FY27e Net Div Yld (%)N/A
Range: 3.0 - 8.0
✗
Div Payout Ratio21.56%
Range: 30 - 55Rank 50/280
–
Current EV/EBITDA5.7x
Range: N/ARank 61/280
✓
Current P/TBV0.96x
Range: 0.8x - 2.0xRank 67/280
✓
Current P/B0.96x
Range: 0.8x - 2.0xRank 79/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
5.8x
FY26e P/E
Forward estimate
N/A
FY27e P/E
Forward estimate
N/A
Current P/B
Price-to-Book
0.96x
Current P/TBV
Tangible Book Value
0.96x
Current EV/EBITDA
Enterprise Value
5.7x
FY26e EV/EBITDA
Forward estimate
N/A
FY27e EV/EBITDA
Forward estimate
N/A

Dividend

JEGI does not currently pay a significant dividend.

—
No dividend data available for this stock.

3. Profitability

Score: 54/280

How profitable is JEGI relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin93.5%
Range: 15 - 30Rank 34/280
–
T12 FCF Margin0.0%
Range: N/ARank 195/280
–
FY27e RoEN/A
Range: 10 - 16
–
FY26 EPS GrowthN/A
Range: 8 - 15
–
FY27e EPS GrowthN/A
Range: 6 - 12
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
93.5%
Current RoCE
18.3%
FY27e RoE
N/A
T12 FCF Margin
0.0%

4. Solvency

Score: 45/280

How strong is JEGI's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.08x
Range: 0.5x - 1.5xRank 52/280
–
Interest Coverage RatioRank 28
Range: N/ARank 28/280
–
Net Leverage RatioN/A
Range: N/A
–
Altman Z-Score (Manufacturing)16.62
Range: N/ARank 52/280
–
Z-Score (Non Manufacturing)Rank 52
Range: N/ARank 52/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
0.08x
Net Leverage Ratio
N/A
Interest Coverage
Rank 28
T12 FCF Margin
0.0%

Altman Z-Score

16.62
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 179/280

How efficiently does JEGI deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.18x
Range: N/ARank 192/280
–
TTM CAPEX/SalesN/A
Range: 1 - 3
–
Working Capital Turnover5.87x
Range: N/ARank 75/280
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#179/280
Best (1)Worst (280)

6. Market Trading

Score: 67/280

How liquid and actively traded is JEGI?

1/2
market trading criteria met
–
Intraday Sentiment (%)N/A
Range: 40 - 75
–
10D-Avg v/s 3M-Avg Vol147%
Range: N/ARank 50/280
✓
Avg Directional Index 30D28.6
Range: 012 - 45Rank 41/280
–
Parabolic SAR133.80
Range: N/ARank 256/280
–
Stock Rating RankN/A
Range: N/A
Market Cap
£807,741,219
Enterprise Value
£840,122,219

Trading Volume

7. Technical

Score: 140/280

What do the technical indicators say about JEGI?

0/5
technical criteria met
–
CMP v/s 52-WH-11.8%
£1.53£1.25
-11.8%CMP: £1.35
Range: N/ARank 142/280
–
CMP v/s 52-WL8.4%
£1.53£1.25
+8.4%CMP: £1.35
Range: N/ARank 47/280
–
RSI 14D16.7
016.7 - Oversold100
Range: N/ARank 100/280
–
MA50 - MA200Bullish
£1.44+0.01£1.45
Range: N/ARank 193/280
–
MACD Rank-0.60
Golden Cross
MACD: -0.60
Range: N/A

RSI (14 Day)

16.7
Oversold
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£1.45
200 SMA£1.44
SignalGolden Cross (Bullish)
MACD-0.60

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does JEGI compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
JEGI#21310325544567140
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for JPMorgan European Growth & Income PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.